An overview of the thrombolysis and angioplasty in acute myocardial infarction (TAMI) trials.
Topol
E J
EJ
Division of Cardiology, University of Michigan Medical Center, Ann Arbor 48109-0022.
D000800:Angioplasty, Balloon; D003327:Coronary Disease / Q000209:etiology; D003331:Coronary Vessels; D004357:Drug Synergism; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy / Q000628:therapy*; D011897:Random Allocation; D012008:Recurrence; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use; D014654:Vascular Patency
D006493:Heparin; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator